<DOC>
	<DOCNO>NCT02844387</DOCNO>
	<brief_summary>This study evaluate nutritional supplement arginine supportive measure patient unresectable metastatic brain tumor receive radiation therapy palliative intent</brief_summary>
	<brief_title>Supplementation L-arginine Patients With Non-resectable Brain Metastases</brief_title>
	<detailed_description>Brain metastasis , common intracranial tumor , associate neurological disability short survival time . For selected patient outcome improve achieving great local control . Virtually cancer patient brain metastasis receive radiotherapy ; majority part primary treatment others connection surgery palliation . Agents increase sensitivity cancer cell radiation may improve control disease . Previous data indicate arginine supplementation modify metabolism cancer immune cell make tumor susceptible standard treatment like radiation . In phase 1/2 comparative study investigator investigate whether 10 mg arginine oral supplementation ( compare placebo administration ) administer twice day prior radiation therapy modify tumor metabolism , immune response effect radiation . The primary end-points safety toxicity arginine , quality-of-life clinical response . The secondary end-points image response neurological progression-free survival . Additional exploratory end-points include intensity radiation administer , effect tumor metabolism magnetic resonance spectroscopy , immune response cytokine pattern serum , body composition nutritional parameter , overall survival progression free survival</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Patients pathologyconfirmed diagnostic solid cancer measurable brain metastasis CT scan and/or MRI Unresectable criterion neurosurgeon Recursive partition analysis ( RPA ) Radiation Therapy Oncology Group ( RTOG ) class II ( Karnofsky 's performance score â‰¥ 70 extracranial metastasis and/or noncontrolled primary tumor ) Measurable brain lesion/s contrastenhanced CT MRI Absolute granulocyte count equal 2000/mm3 Hemoglobin equal 9 g/L ( patient low level transfuse randomization ) Normal renal laboratory ( serum creatinine &lt; 1.5 mg/dL 24h creatinine clearance &gt; 60 mL/min ) Normal hepatic function ( aspartate aminotransferase alanine aminotransferase &lt; 2.5 time upper limit normal ) Stable body weight composition least one month prior enrollment Prior treatment brain metastasis and/or brain tumor . Primary brain tumor Hematologic malignancy Solid tumor germinal origin Contraindication external radiation therapy . Allergy Larginine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>cancer</keyword>
	<keyword>brain</keyword>
	<keyword>arginine</keyword>
	<keyword>radiation</keyword>
</DOC>